Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Brain Neoplasms 4Suspected Central Nervous System Tumors 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Lymphoma 1Intracranial Arteriovenous Malformations 1Intracranial Aneurysm 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 8Temozolomide 6Topotecan 5Melphalan 5Granulocyte Colony-Stimulating Factor 5X-Rays 4Phantoms, Imaging 4Irinotecan 4palbociclib 3fludarabine 3Vincristine 3Specimen Handling 3Sirolimus 3Magnetic Resonance Spectroscopy 3Busulfan 3Bone Marrow Transplantation 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2ivosidenib 2irinotecan sucrosofate 2cabozantinib 2abemaciclib 2Zoledronic Acid 2Vemurafenib 2Nuclear Medicine Department, Hospital 2Nivolumab 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Indocyanine Green × CNS × Clear all
NCT04084067 2026-04-30

Indocyanine Green (ICG) Guided Tumor Resection

St. Jude Children's Research Hospital

Phase 1 Recruiting
230 enrolled
CNSGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lymphoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡